GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare India: Statutory Auditor Kalyaniwalla & Mistry Resigns

MANAGEMENT ▼ Concern Flagged MEDIUM RISK
📅 Filed on BSE: 30 Apr 2026, 05:52 PM IST  ·  BSE ID: e2bbc98e-f1ac-4365-8216-3a3a1d8b5d90
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's auditor just quit because the company refused to pay higher audit fees for 2026.
🤖 AI Summary
  • Kalyaniwalla & Mistry LLP resigns as statutory auditor with immediate effect, 30 April 2026
  • Appointed for five-year term (FY 2024–2028) following 25 April 2024 annual general meeting
  • Resignation triggered by company rejection of auditor's FY 2026 fee increase request on 29 April 2026
  • Auditor cites inability to undertake audit at proposed fee levels per ICAI Standards on Auditing
  • No audit evidence gaps or other material circumstances disclosed in resignation letter
🔢 Key Numbers — exact figures from BSE filing, not rounded
Auditor appointment term
Five years (FY 2024–2028)
Fee disagreement date
29 April 2026 (company rejection)
Resignation effective date
30 April 2026
🏢 How This Affects the Company
⚙️
Operational Impact
Sanofi Consumer Healthcare India must appoint a replacement statutory auditor before 31 May 2026 per SEBI regulations. Interim audit arrangements or delayed FY 2025 audit completion is a near-term operational risk.
⚠️
Risk Impact
Auditor vacancy creates governance gap and potential audit timeline delays. Auditor dissatisfaction on fees signals compensation expectations misalignment and increases successor auditor appointment execution risk.
👥 What This Means For Shareholders
✅
Action Required
Monitor BSE disclosures for new statutory auditor appointment announcement and audit completion timeline confirmation.
👤
Who Is Affected
All shareholders. Delayed or incomplete FY 2025 audit affects financial statement certification and dividend distribution eligibility.
🔍
Management Signal
Management prioritized cost containment over auditor compensation alignment, indicating tighter budget controls during earnings pressure.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
New statutory auditor appointment filing under Reg 30 — verify appointment within 30 days
FY 2025 audit completion and financial results declaration — monitor for delays or qualifier notes
Next Board meeting minutes for auditor appointment resolution and successor fee negotiations
MEDIUM RISK Auditor vacancy and audit timeline risk during critical financial certification period. Fee conflict signals internal governance tension.
💡 Investor Takeaway
Statutory auditor Kalyaniwalla & Mistry LLP resigned 30 April 2026 over FY 2026 fee increase rejection. No audit evidence or financial irregularity cited. Company must appoint successor auditor; timing and audit completion delays for FY 2025 are material monitoring points.
⚖️ Strengths & Concerns

⚠️ Concerns

  • Auditor resignation creates immediate governance vacancy requiring urgent replacement within regulatory deadline.
  • Fee disagreement signals potential cost-cutting pressure on compliance functions during critical FY 2025 audit period.
📅 Company Track Record
Sanofi Consumer Healthcare India Limited incorporated 11 January 2023 (CIN: L21002MH2023PLC402652). Limited public financial history available. Company is a consumer healthcare subsidiary of Sanofi group.

Based on publicly available historical data. For context only.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.